Variant report
Variant | esv3361814 |
---|---|
Chromosome Location | chr5:114739334-114739772 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs184156404 | chr5:114739344-114739345 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs568756070 | chr5:114739347-114739348 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs112187205 | chr5:114739349-114739350 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs556097796 | chr5:114739364-114739365 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs2260998 | chr5:114739378-114739379 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs142332041 | chr5:114739437-114739438 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs2260996 | chr5:114739461-114739462 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs540807837 | chr5:114739462-114739463 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs75258057 | chr5:114739483-114739484 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs74630380 | chr5:114739488-114739489 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs559242565 | chr5:114739492-114739493 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs145718038 | chr5:114739520-114739521 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs563651323 | chr5:114739524-114739525 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs186740940 | chr5:114739530-114739531 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs150951854 | chr5:114739535-114739536 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs191591556 | chr5:114739589-114739590 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs148996626 | chr5:114739611-114739612 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559883185 | chr5:114739632-114739633 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs369268580 | chr5:114739633-114739634 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs7718052 | chr5:114739651-114739652 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs184175643 | chr5:114739682-114739683 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs376294847 | chr5:114739706-114739707 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs368550582 | chr5:114739709-114739710 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs201765889 | chr5:114739720-114739721 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs199795946 | chr5:114739721-114739722 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs200629748 | chr5:114739722-114739723 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs550586362 | chr5:114739729-114739730 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs568792848 | chr5:114739742-114739743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Sezary syndrome | 18413736 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:114737800-114739400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
2 | chr5:114737800-114739400 | Enhancers | NHDF-Ad | bronchial |
3 | chr5:114737800-114739800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr5:114738000-114739400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
5 | chr5:114738600-114739400 | Enhancers | NH-A | brain |
6 | chr5:114738600-114739600 | Weak transcription | Ovary | ovary |
7 | chr5:114738800-114739600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr5:114738800-114739600 | Enhancers | Osteobl | bone |
9 | chr5:114739000-114739400 | Enhancers | Muscle Satellite Cultured Cells | -- |
10 | chr5:114739200-114739400 | Enhancers | Aorta | Aorta |
11 | chr5:114739200-114739400 | Enhancers | Lung | lung |
12 | chr5:114739600-114739800 | Enhancers | Ovary | ovary |
13 | chr5:114739600-114741200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |